Atrial Fibrillation Clinical Trials in Schwerin
2 recruitingSchwerin, Germany
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases
Heart FailureAtrial FibrillationCoronary Artery Disease
Helios Health Institute GmbH24,000 enrolled10 locationsNCT04844944